UPPER URINARY TRACT OBSTRUCTION is a common cause of renal dysfunction in both children and adults and is characterized by collecting system dilatation, significant tubulointerstitial fibrosis, and a progressive loss in renal parenchymal mass secondary to apoptotic tubular cell death (33) . Renal tubular cells are extremely sensitive to obstruction-induced apoptosis with peak apoptotic cell death occurring within 1 to 2 wk of renal obstruction (3, 4) . A number of inflammatory mediators and growth factors have been implicated in obstruction-induced renal apoptosis, most notably transforming growth factor (TGF)-␤1 and TNF-␣ (8, 21, 24 -26) . Interleukin (IL)-18 is a proinflammatory cytokine implicated in the pathogenesis of many inflammatory renal diseases, including urinary tract infection, ischemia-reperfusion injury, autoimmune conditions, allograft rejection, and obstructive nephropathy (1, 5, 10, 18, 31) . While IL-18's proinflammatory action has been attributed, in part, to the induction of downstream cytokine activity (27, 34, 35) , we previously showed that IL-18 induces renal fibrosis and tubular cell epithelial-mesenchymal transition independent of TGF-␤1 and TNF-␣ activity (1) .
IL-18 is synthesized as a biologically inactive precursor (pro-IL-18) and is cleaved into an active molecule by the intracellular cysteine protease ICE or caspase-1 (6, 12) . In humans, urinary IL-18 levels have been shown to be a sensitive and early marker of renal tubular damage from ischemic and posttransplantation ATN, with elevated urinary IL-18 levels predictive of acute tubular injury before creatinine levels and urine output become altered (30, 31) . In animal models of renal ischemia-reperfusion injury, IL-18 has been shown to exacerbate acute tubular necrosis (7, 22, 23) , and Liang et al. (19) demonstrated that direct IL-18 stimulation induces apoptosis in renal tubular cells (TECs) in vitro. IL-18 has been shown to induce apoptosis in a variety of cells through both TNF-␣-and Fas/FasL-dependent mechanisms (11, 20, 28) . In endothelial cells, IL-18 upregulates surface TNFR1 expression and thereby increases the susceptibility of endothelial cells to undergo TNF-induced, but not Fas-induced, apoptosis (20) . On the other hand, IL-18 enhances FasL expression and induces apoptosis in NK cells and human myelomonocytic KG-1 cells through a Fas-dependent mechanism (15, 28) . A Fas-dependent mechanism of IL-18-induced apoptosis has also been reported in hepatocytes (11) .
Since IL-18 has recently been shown to have an important role in obstruction-induced renal fibrosis and TEC injury independent of TGF-␤1 and TNF-␣ activity (1), we hypothesized that IL-18 is an important mediator of obstruction-induced renal tubular cell apoptosis through a Fas-dependent mechanism. To study this, we examined renal cortical IL-18 production, apoptotic cell death, active caspase expression, and Fas/ FasL expression in male C57B16 wild-type (WT) mice and mice transgenic for IL-18BP using a well-established model of unilateral ureteral obstruction (UUO). C57BL6 mice transgenic for IL-18-binding protein (IL-18BP Tg) have been previously demonstrated to overexpress human IL-18-binding protein isoform a and reliably inhibit IL-18 activity (9). In addition, human proximal tubular cells (HK-2) were directly stimulated with IL-18 and the cells were subsequently examined for apoptotic cell death, FasL expression, and active caspase expression. (9) . The genotype of the mice was confirmed with a PCR analysis of extracted DNA samples from tail snips (5= primer, 5=-ACA CCT GTC TCG CAG ACC AC-3= and 3= primer, 5=-TCA GCT GCT CCA GCA CCA A-3=) as described by Fantuzzi et al. (9) and overexpression of serum levels of human IL-18BP was confirmed using an ELISA (Human IL-18BP DuoSet ELISA; R&D Systems) (1) before utilization of the animals.
MATERIALS AND METHODS

Animals
Male WT or IL-18BP Tg mice weighing 25-30 g (6 animals per group) were anesthetized with isofluorane and subjected to either sham operation or left UUO. For obstructed animals, the left ureter was isolated and completely ligated with 5-0 silk suture. Shamoperated mice underwent an identical surgical procedure without ureteral ligation. One or two weeks postoperatively, mice were reanesthetized, the left kidneys were removed and snap-frozen in liquid nitrogen, and the animals were subsequently killed.
Tissue homogenization. A portion of each renal cortex was homogenized after the samples had been diluted in 10 Vol of homogenate buffer per gram of tissue [10 mM HEPES (pH 7.9), 10 mM KCl, 0.1 mM EGTA, 1 mM DTT, and Complete Protease Inhibitor tabs (Boehringer Mannheim, Indianapolis, IN)] using a vertishear tissue homogenizer. Renal homogenates were then centrifuged at 3,000 g for 15 min at 4°C, and the supernatants were stored at Ϫ80°C until the ELISA assays or Western blots could be performed.
Cell culture and IL-18 stimulation. The human proximal tubular cell line HK-2 was cultured in keratinocyte serum-free medium ϩ 5 ng/ml epidermal growth factor and 40 mg/ml bovine extract ϩ 100 U/ml penicillin and 100 U/ml of streptomycin. The cells were passaged weekly by trypsinization (0.05% Trypsin-EDTA) following formation of a confluent monolayer and placed in serum-free media 24 h before stimulation. Recombinant mature IL-18 (R&D Systems, Minneapolis, MN) was added to the cells at concentrations of 0.1 ng/ml, 1 ng/ml, 10 ng/ml, or 100 ng/ml, with untreated cells serving as controls. The cells were exposed to the single dose of IL-18 vs. untreated media for 3 days and both supernatants and cell lysates were harvested (4 plates per treatment group). FasL siRNA transfection. HK-2 cells (2.5 ϫ 10 5 cells/well) were cultured in a six-well dish and placed in serum-free medium 18 h before transfection. Cells were than reversely transfected with 40 pmol siRNA (Silencer Select Negative Control #1 siRNA or Silencer Select Predesigned human Fas ligand siRNA, Ambion) using 6.5 l of Lipofectamine 2000 reagent (Invitrogen). After 6 h, cells were treated with either vehicle or 100 ng/ml IL-18 (R&D Systems) for 3 days. Conditioned medium, total RNA, and protein were collected for future ELISA, RT-PCR, and Western blot analysis.
Apoptosis ELISA. A portion of the renal cortex from each kidney was homogenized with a vertishear tissue homogenizer after 4 Vol of ice-cold 50 mM Tris·HCl (pH 7.4) was added. The samples were agitated on ice for 30 min. Four volumes of 0.1% Triton X-100 were added to each sample, and the samples were agitated on ice for 60 min. The samples were then centrifuged at 13,000 rpm for 20 min at 4°C and supernatants were collected. HK-2 cells were cultured and stimulated for 3 days with increasing concentrations of IL-18 as described above. The treated and untreated culture medium was collected and centrifuged at 13,000 rpm for 5 min at 4°C and supernatants were collected. A photometric enzyme immunoassay for the quantitative determination of cytoplasmic histone-associated DNA fragments representative of apoptosis (Cell Death Detection ELISA Plus, Roche Diagnostics; Mannheim, Germany) was performed using 20 l of supernatant from each tissue or cell culture sample as described by the manufacturer. The samples were tested in duplicate, and the results were expressed as optical density per milligram of protein. The assay allows for the specific detection of mono-and oligonucleosomes in as few as 5 ϫ 10 2 cell equivalents per well. TdT-mediated dUTP nick end labeling assay. Three transverse 6-m renal tissue sections were prepared from each sample using a cryostat and fixed in 4% paraformaldehyde and 30% sucrose. Fluorometric DNA strand breaks representative of apoptosis were detected in each tissue section using terminal deoxynucleotidyl transferase incorporation of fluorescein-dUTP (ApopTag Red in situ Apoptosis Detection Kit, Temecula, CA). After cellular permeabilization with 20 g/ml Proteinase K for 15 min, the tissue sections were exposed to terminal deoxynucleotidyl transferase fluorescein labeling for 1 h. The tissue sections were then washed in PBS and exposed to AntiDigoxigenin conjugate for 30 min. The tissue was then washed again and counterstained (10 g/ml bis-benzimide) for 10 min. The specimens were mounted in an antiquenching medium (ProLong Antifade Kit; Molecular Probes, Eugene, OR) and maintained at Ϫ4°C until the microscopic examination could be performed. The number of fluorescent nuclei was quantified per high-powered field in each treatment group and compared. Samples were analyzed in triplicate. The characteristic morphologic features of apoptosis (i.e., nuclear condensation) were also correlated with nuclear fluorescence.
ApopTag peroxidase in situ apoptosis detection. Three transverse 6-m paraffin-embedded renal tissue sections were obtained from each sample, deparaffinized, and pretreated with proteinase K (20 g/ml) for 15 min. Following quenching of endogenous peroxidase activity in 3% hydrogen peroxide, samples were incubated with working-strength terminal deoxynucleotidyl transferase (TdT) enzyme for 1 h according to the manufacturer's instructions (kit S7100; Chemicon, Temecula, CA). Tissue samples were then incubated with anti-digoxignenin conjugate for 30 min, washed, and developed by applying peroxidase substrate (DAB, diaminobenzidine) to each specimen for 5 min. DNA strand breaks representative of apoptosis were detected in each tissue section using terminal deoxynucleotidyl transferase incorporation of digoxigenin-nucleotide. Slides were then counterstained with hematoxylin and eosin and the cell types undergoing apoptosis were determined.
Flow cytometry. Apoptosis in HK-2 cells induced by IL-18 was quantitated by flow cytometry using an Annexin V-FITC Apoptosis Detection Kit I (BD Biosciences). HK-2 cells were exposed to IL-18 stimulation or control media as described above, then harvested, and washed twice with cold PBS. Cells (1 ϫ 10 5 ) were resuspended in 100 l of 1ϫ binding buffer. Five microliters of annexin V-FITC and 5 l of propidium iodide were then added to the cells, and the cells were incubated for 15 min at room temperature in darkness. An additional 400 l of 1ϫ binding buffer were then added to each sample. Apoptotic cell death was analyzed using FACScan and CellQuest software (BD Biosciences).
Western blot analysis. Protein extracts from homogenized samples (30 g/lane) or cell lysates (20 g/lane) were subjected to SDS-PAGE electrophoresis on a Tris-glycine gel and transferred to a polyvinylidene fluoride membrane. Immunoblotting was performed by incubating each membrane in 5% dry milk for 1 h, followed by incubation with an anti-caspase-3 p17 antibody (1:500 overnight at 4°C, Cell Signaling) or an anti-caspase-8 p20 antibody [1:200 for 2 h at room temperature (RT); Santa Cruz Biotechnology, Santa Cruz, CA]. After being washed three times in TBST, each membrane was incubated for 1 h at RT with a peroxidase-conjugated secondary antibody (1:2,000 for caspase-3, 1:5,000 for caspase-8). Equivalent protein loading in each lane was confirmed by stripping and reblotting each membrane for GAPDH (1:20,000 for 30 min at RT, secondary 1:20,000 for 30 min at RT; Biodesign International, Saco, ME). The membranes were developed using enhanced chemiluminescence (Amersham Pharmacia Biotech, Piscataway, NJ), and the density of each band was determined using NIH image analysis software and expressed as a percentage of GAPDH density.
Real-time PCR for Fas and FasL. Total RNA was extracted from renal cortical tissue or cell lysates by homogenization in TRIzol (GIBCO BRL, Gaithersburg, MD) and then isolated by precipitation with chloroform and isopropanol. Total RNA (0.5 g) was subjected to cDNA synthesis using iScript (Bio-Rad, Hercules, CA). cDNA from each sample was analyzed for Fas or Fas-L using a TaqMan gene expression assay (RT-PCR; Applied Biosystems, Foster City, CA). FAM Dye/MGB-labeled probes for GAPDH (4352932E Applied Biosystems) served as endogenous controls. Primers used were Fas (Mm00433237_m1; HS00163653_m1) and FasL (Mm00438864_m1; Hs00899442_m1).
Statistical analysis. Data are presented as means Ϯ SE. Differences at the 95% confidence level were considered significant. The experiment groups were compared using one-way ANOVA with post hoc Bonferroni-Dunn (JMP 5.0.1). For cell culture experiments using varying concentrations of IL-18, a multiple comparison analysis was performed in all pairs using Tukey-Kramer honestly significant difference. Data are presented as means Ϯ SD.
RESULTS
Obstruction-induced apoptosis.
To assess the role of IL-18 in obstructed-induced renal cell apoptosis, samples from each treatment group were analyzed quantitatively for cytoplasmic histone-associated DNA fragments, a marker of apoptosis, and examined histologically for apoptotic nuclei with a TdT-mediated dUTP nick end labeling and ApopTag assay. Shamtreated samples demonstrated low levels of cytoplasmic histone-associated DNA fragments and minimal apoptotic staining in each treatment group. In contrast, WT animals exhibited a significant increase in cytoplasmic histone-associated DNA fragments (Fig. 1A) and apoptotic cell death (Fig. 1, B and C) in response to both 1 and 2 wk of renal obstruction, with the number of apoptotic nuclei most prominent at the 2-wk time point. Apoptotic nuclei localized to both tubular epithelial cells, and to a lesser extent, the interstitium on immunohistochemical staining (Fig. 1C) . IL-18BP Tg animals, on the other hand, exhibited no increase in cytoplasmic histone-associated DNA fragments and a significant reduction in apoptotic cell death in response to both 1 and 2 wk of renal obstruction.
IL-18-induced apoptosis in TEC.
IL-18's ability to directly stimulate tubular epithelial cell apoptosis was subsequently evaluated by exposing HK-2 cells to various concentrations of IL-18 in vitro. A significant increase in cytoplasmic histoneassociated DNA fragments (Fig. 2) , and an increase in the percentage of apoptosis as determined by flow cytometry (Fig. 3,  A and B) , was detected in cells stimulated with IL-18 in a dose-dependent fashion. These findings, in conjunction with our observations in vivo, suggest that IL-18 is an important mediator of renal cell apoptosis.
Caspase activation. To elucidate the signaling pathway involved in IL-18-mediated renal cell apoptosis, active caspase-8 and -3 expression was evaluated in renal cortical tissue samples and in HK-2 cells in response to direct IL-18 stimulation in vitro. Active caspase-8 and -3 expression remained low in sham-treated animals, but increased significantly in response to 1 wk, and increased further in response to 2 wk of renal obstruction (Fig. 4, A and B) . A marked reduction in active caspase-8 and -3 expression was detected in the IL-18BP Tg mice exposed to the same degree of obstruction. HK-2 cells subjected to graded IL-18 stimulation similarly demonstrated a significant increase in active caspase-8 and -3 expression in response to IL-18 in a dose-dependent fashion (Fig. 5) . These data suggest that IL-18's regulatory role in renal cell apoptosis involves caspase signaling.
Fas and FasL expression. Since Fas and Fas ligand expression are increased during renal obstruction (4), and IL-18 stimulates FasL expression (11, 15) and Fas-FasL-dependent cytotoxity in a variety of cells (13), the impact of IL-18 activity on Fas/Fas ligand expression during renal obstruction and in HK-2 cells in vitro was evaluated. As expected, Fas and FasL expression increased significantly in WT mice in response to 1 and 2 wk of renal obstruction (Fig. 6 ). FasL expression, but not Fas expression, was significantly reduced; however, in IL-18BP Tg mice exposed to the same degree of obstruction. These results demonstrate that IL-18 induces apoptotic signaling in renal cells, in part, by stimulating FasL expression and suggest a Fas-dependent pathway for IL-18-induced renal cell apoptosis.
HK-2 cell FasL expression and impact of FasL knockdown during IL-18 stimulation.
To further evaluate FasL as a mediator of IL-18-induced renal tubular cell apoptosis, FasL expression was evaluated in vitro in HK-2 cells exposed to IL-18. FasL expression was significantly higher in cells exposed to IL-18 stimulation (100 ng/ml for 3 days) compared with controls (Fig. 7A) , and cells exposed to siRNA knockdown of FasL before IL-18 stimulation exhibited a significant reduction in FasL gene expression (Fig. 7B) , apoptotic cell death (Fig.   Fig. 5 . HK-2 active caspase-3 and caspase-8 expression following IL-18 stimulation in vitro. A: gel photograph and densitometric analysis of active caspase-8 expression represented as a percentage of GAPDH in HK-2 cells following 3 days of cell stimulation with varying concentrations of recombinant human IL-18 (0 -100 ng/ml). B: gel photograph and densitometric analysis of active caspase-3 expression represented as a percentage of GAPDH in HK-2 following 3 days of cell stimulation with varying concentrations of recombinant human IL-18 (0 -100 ng/ml). 7C), and active caspase 3 expression (Fig. 7D) . These results provide evidence that IL-18 induces renal tubular cell apoptosis by stimulating FasL expression.
DISCUSSION
The proinflammatory cytokine, IL-18, has been shown to induce apoptosis in HK-2 cells in vitro (19) and has been identified as an important mediator of obstruction-induced renal fibrosis and tubular cell injury independent of TGF-␤1 and TNF-␣ activity (1) . This is the first study to demonstrate that IL-18 has a significant role in proapoptotic signaling during renal obstruction, and it reveals that IL-18's proapoptotic activity is mediated, in part, through a Fas/FasL-dependent pathway. IL-18 induces the gene expression of several proapoptotic factors including TNF-␣, IL-1, Fas ligand, and multiple chemokines (7), and it has been shown to stimulate apoptotic cell death in a variety of cells through both TNF-␣-and Fas-dependent mechanisms (11, 20, 28) . Since IL-18 has previously been shown to mediate renal tubular cell injury during obstruction independent of TNF-␣ and TGF-␤1 activity (1), the role of IL-18 in obstruction-induced apoptosis and the impact of IL-18 on Fas/FasL-dependent apoptotic signaling was evaluated.
We previously showed that renal cortical IL-18 levels are three times higher in kidneys exposed to 1 or 2 wk of obstruction compared with sham-operated controls and that IL-18 neutralization ameliorates obstruction-induced renal fibrosis (1). Our current findings indicate that IL-18 neutralization also significantly reduces obstruction-induced renal cell apoptosis and cytoplasmic histone-associated DNA fragment levels at both 1 and 2 wk of obstruction. IL-18's direct cytotoxic effect on renal tubular cells was further evaluated in vitro, with results demonstrating a dose-dependent increase in cytoplasmic histone-associated DNA fragments and the percentage of apoptosis as determined by flow cytometry in HK-2 cells stimulated with IL-18. These results corroborate previous observations by Liang et al. (19) in HK-2 cells. While a general reduction in inflammatory signaling during IL-18 neutralization may lead to reduced apoptotic cell death in vivo, these results indicate that IL-18 has a direct proapoptotic effect in tubular epithelial cells.
IL-18's impact on proapoptotic signaling was subsequently evaluated by examining caspase-8 and caspase-3 activity during UUO and in TECs in vitro. Active caspase-8 and -3 expression was significantly increased at 1 wk and increased further after 2 wk of obstruction. IL-18 neutralization, however, dramatically reduced obstruction-induced active caspase-8 and -3 expression at both time points. This suggests that IL-18 activates an extrinsic proapoptotic signaling pathway during renal obstruction. Similarly, upon direct stimulation of HK-2 cells in vitro, IL-18 induced a dose-dependent increase in both active caspase-8 and active caspase-3 expression. Since our previous work elucidated IL-18's significant role in obstruction-induced renal fibrosis and TEC injury in vitro independent of any effect on TGF-␤1 and TNF-␣ activity (1), we hypothesized that IL-18 stimulates extrinsic proapoptotic signaling through a Fas/FasL-dependent mechanism.
Upon FasL binding to the death receptor Fas, the adaptor protein FADD is recruited to the receptor, resulting in caspase-8 activation and subsequent apoptotic cell death (16, 32) . It has previously been shown that the Fas/FasL system regulates ischemia-induced cardiac myocyte and renal cell apoptosis, as mice with disrupted Fas/FasL systems are protected from myocyte and tubular epithelial cell death (14, 17, 29) . While IL-18's proapoptotic activity is mediated through a TNF-␣-dependent mechanism in some cells (20) , IL-18 has been shown to upregulate Fas/FasL expression and activate proapoptotic signaling through a Fas/FasL-dependent pathway in cardiac endothelial cells, NK cells, human myelomonocytic KG-1 cells, and hepatocytes (2, 11, 15, 28) . Our results demonstrate that Fas and FasL expression are significantly increased in response to renal obstruction, and furthermore, that obstruction-induced FasL expression is significantly reduced in the presence of IL-18 neutralization. Our in vitro studies similarly reveal that FasL expression is significantly increased in TECs in response to IL-18 stimulation and demonstrate that cells exposed to siRNA knockdown of FasL before IL-18 stimulation exhibit a significant reduction in FasL gene expression, apoptotic cell death, and active caspase-3 expression. This suggests that IL-18 stimulates FasL expression in TECs in vitro and during obstruction and that IL-18-mediated renal cell apoptosis is dependent, in part, on the Fas/FasL signaling pathway.
Despite advancements in urologic surgery, upper urinary tract obstruction remains an important cause of renal failure. The development of renal injury during obstruction is primarily a consequence of increased proinflammatory signaling and the subsequent release and activation of multiple profibrotic and proapoptotic mediators. This is the first study to demonstrate that IL-18 stimulates renal tubular cell apoptosis and proapoptotic signaling through a Fas/FasL-dependent pathway during renal obstruction and in TECs in vitro. A greater understanding of IL-18's role in renal injury and the mechanisms involved in IL-18-induced apoptosis may provide new therapeutic strategies to protect against renal dysfunction in the future.
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